E-LIB Suche - Ergebnisse für: Perez-Valderrama, B.

1

Impact of intestinal dysbiosis-related drugs on the efficac..:

Pérez-Ruiz, E. ; Jiménez-Castro, J. ; Berciano-Guerrero, M.-A....
Clinical and Translational Oncology. 22 (2020) 10 - p. 1778-1785 , 2020

Link: https://doi.org/10.1007/..

2

Active surveillance as a successful management strategy for..:

Escudero-Ávila, R. ; Rodríguez-Castaño, J. D. ; Osman, I....
Clinical and Translational Oncology. 21 (2018) 6 - p. 796-804 , 2018

Link: https://doi.org/10.1007/..

3

SEOM clinical guideline for treatment of muscle-invasive an..:

González del Alba, A. ; De Velasco, G. ; Lainez, N....
Clinical and Translational Oncology. 21 (2018) 1 - p. 64-74 , 2018

Link: https://doi.org/10.1007/..

4

Correction to: SEOM clinical guidelines for the treatment o..:

Cassinello, J. ; Arranz, J. Á. ; Piulats, J. M....
Clinical and Translational Oncology. 20 (2018) 1 - p. 110-111 , 2018

Link: https://doi.org/10.1007/..

5

SEOM clinical guidelines for the treatment of metastatic pr..:

Cassinello, J. ; Arranz, J. Á. ; Piulats, J. M....
Clinical and Translational Oncology. 20 (2017) 1 - p. 57-68 , 2017

Link: https://doi.org/10.1007/..

6

HIF pathway and c-Myc as biomarkers for response to sunitin..:

Maroto, P ; Esteban, E ; Fernández Parra, E...
OncoTargets and Therapy. 10 (2017) - p. 4635-4643 , 2017

Link: https://doi.org/10.2147/..

7

Epidemiological Estimation and Flow of Patients with Advanc..:

Grande, E ; Pérez-Valderrama, B ; García del Muro, X...
Value in Health. 19 (2016) 7 - p. A716 , 2016

Link: https://doi.org/10.1016/..

8

2540 Experience with radium-223 as a systemic treatment for..:

Grande, E. ; Pinto, A. ; Dur´n, I....
European Journal of Cancer. 51 (2015) - p. S488-S489 , 2015

Link: https://doi.org/10.1016/..

9

2638 Effectiveness of 2nd-line and subsequent therapies aft..:

Arija, J.A. Arranz ; Pérez-Valderrama, B. ; González-Larriba, J.L....
European Journal of Cancer. 51 (2015) - p. S526 , 2015

Link: https://doi.org/10.1016/..

10

2602 Pazopanib (Pz) as first line for metastatic renal carc..:

Perez-Valderrama, B. ; Arija, J.A. Arranz ; Vidal, M.J. Méndez...
European Journal of Cancer. 51 (2015) - p. S512 , 2015

Link: https://doi.org/10.1016/..

11

2623 Prospective validation of prognostic classifications i..:

Arija, J.A. Arranz ; Vazquez-Estevez, S. ; Perez-Valderrama, B....
European Journal of Cancer. 51 (2015) - p. S520 , 2015

Link: https://doi.org/10.1016/..

12

Immunotherapy in prostate cancer: review of the current evi..:

Fernández-García, E. M. ; Vera-Badillo, F. E. ; Perez-Valderrama, B...
Clinical and Translational Oncology. 17 (2014) 5 - p. 339-357 , 2014

Link: https://doi.org/10.1007/..

13

28P 3-year follow-up analysis of disease-free survival in C..:

Stenner-Liewen, F. ; Galsky, M. ; Bajorin, D....
Immuno-Oncology and Technology. 20 (2023) - p. 100497 , 2023

Link: https://doi.org/10.1016/..

14

SEOM clinical guideline for treatment of muscle-invasive an..:

González-del-Alba, Aránzazu ; De Velasco, G ; Lainez, N...
Clinical & Translational Oncology. , 2019

Link: https://ddd.uab.cat/reco..

15

SEOM clinical guideline for treatment of muscle-invasive an..:

González Del Alba, A ; De Velasco, G ; Lainez, N...
http://hdl.handle.net/10668/13329. , 2018

Link: http://hdl.handle.net/10..